CASI Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-25.9M | $-27.4M | $1.5M | $7.8M |
| FY2021 | $-26.8M | $-35.8M | $8.9M | $7.8M |
| FY2022 | $-21.1M | $-26.7M | $5.6M | $7.0M |
| FY2023 | $-20.0M | $-20.2M | $204.0K | $7.2M |
| FY2024 | $-29.2M | $-29.4M | $223.0K | $1.3M |
| FY2025 | $-20.8M | $-20.8M | $16.0K | $3.0M |